Literature DB >> 16155903

Indicative oligodendrocyte dysfunction in spinal cords of human fetuses suffering from a lethal motoneuron disease.

Niklas Pakkasjärvi1, Massimiliano Gentile, Juha Saharinen, Jarno Honkanen, Riitta Herva, Leena Peltonen, Marjo Kestilä.   

Abstract

Human spinal cord development is still poorly understood and detailed molecular analyses of human motoneuron diseases could improve our understanding of the normal developmental processes of the spinal cord. Lethal Congenital Contracture Syndrome (LCCS, MIM 253310) provides a human model to study the early motoneuronal development. A typical phenotype of LCCS fetuses consists of multiple joint contractures, distinct facial features, and hydrops. Tissue pathology is characterized by severe muscle atrophy, lung hypoplasia, and degeneration of the anterior horn of the spinal cord as the hallmark of the syndrome. In this study we performed a global transcript analysis of LCCS spinal cords. The RNA expression profiles of these spinal cords were compared to age-matched healthy control fetuses, aborted for nonrelated causes. In addition, we applied phylogenetic footprinting methods to decipher the mechanisms of transcriptional regulation in the affected transcripts. Changes in transcripts involved with the development of the CNS and oligodendrocytes were obvious and the transcription factor PAX6 was identified as a key regulator during spinal cord development. In addition, transcript pathway analysis clearly indicated genes belonging to groups with neuronal functions to be affected. Our findings support the hypothesis that human motoneurons and oligodendrocytes are dependent on each other during their development and are influenced by distinct transcription factors previously known to act during murine and chick motoneuron development. These data provide valuable information about the molecular pathways putatively active in motoneuron diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16155903     DOI: 10.1002/neu.20185

Source DB:  PubMed          Journal:  J Neurobiol        ISSN: 0022-3034


  5 in total

1.  Myelin gene regulatory factor is a critical transcriptional regulator required for CNS myelination.

Authors:  Ben Emery; Dritan Agalliu; John D Cahoy; Trent A Watkins; Jason C Dugas; Sara B Mulinyawe; Adilijan Ibrahim; Keith L Ligon; David H Rowitch; Ben A Barres
Journal:  Cell       Date:  2009-07-10       Impact factor: 41.582

2.  Mutations in mRNA export mediator GLE1 result in a fetal motoneuron disease.

Authors:  Heidi O Nousiainen; Marjo Kestilä; Niklas Pakkasjärvi; Heli Honkala; Satu Kuure; Jonna Tallila; Katri Vuopala; Jaakko Ignatius; Riitta Herva; Leena Peltonen
Journal:  Nat Genet       Date:  2008-01-20       Impact factor: 38.330

3.  Myelin gene regulatory factor is required for maintenance of myelin and mature oligodendrocyte identity in the adult CNS.

Authors:  Matthias Koenning; Stacey Jackson; Curtis M Hay; Clare Faux; Trevor J Kilpatrick; Melanie Willingham; Ben Emery
Journal:  J Neurosci       Date:  2012-09-05       Impact factor: 6.167

4.  Nuclear export factor RBM15 facilitates the access of DBP5 to mRNA.

Authors:  Andrei S Zolotukhin; Hiroaki Uranishi; Susan Lindtner; Jenifer Bear; George N Pavlakis; Barbara K Felber
Journal:  Nucleic Acids Res       Date:  2009-11       Impact factor: 16.971

5.  Global transcript profiles of fat in monozygotic twins discordant for BMI: pathways behind acquired obesity.

Authors:  Kirsi H Pietiläinen; Jussi Naukkarinen; Aila Rissanen; Juha Saharinen; Pekka Ellonen; Heli Keränen; Anu Suomalainen; Alexandra Götz; Tapani Suortti; Hannele Yki-Järvinen; Matej Oresic; Jaakko Kaprio; Leena Peltonen
Journal:  PLoS Med       Date:  2008-03-11       Impact factor: 11.069

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.